Suzhou Infinory Pharmaceuticals
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- Undisclosed
Investors
- 1
About Suzhou Infinory Pharmaceuticals
Based in Suzhou, China, and established in 2020, Suzhou Infinory Pharmaceuticals, LLC is a biopharmaceutical company primarily engaged in the development of oncolytic virus drug. The company was founded by Yinghui Huang, a tenured professor at the Torrey Pines Molecular Institute in California, United States. In August 2023, the company's oncolytic virus injection, YH01, received implicit approval for clinical trials from the National Medical Products Administration (NMPA). Suzhou Infinory Pharmaceuticals, LLC is committed to the oncolytic virus design, construction, verification, process development, and large-scale production. The company's core products include YH01, a drug targeting triple-negative breast cancer (TNBC) and other four product pipelines. The company also developed an OCDP ™ (Oncolytic Core Design Platform) technology platform that has developed more than ten oncolytic viruses. The company will use the series A1 funds for the Phase I clinical study of the oncolytic virus product YH01.
Who invested in Suzhou Infinory Pharmaceuticals
1 investor across 1 round
See all investors in Suzhou Infinory Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 11, 2024
Amount
Undisclosed
Investors
Questions about Suzhou Infinory Pharmaceuticals
Who invested in Suzhou Infinory Pharmaceuticals?
Suzhou Infinory Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Suzhou Infinory Pharmaceuticals raised?
Suzhou Infinory Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Suzhou Infinory Pharmaceuticals last raise money?
Suzhou Infinory Pharmaceuticals's most recent round on record is a Series A, in Mar 2024.
What does Suzhou Infinory Pharmaceuticals do?
Based in Suzhou, China, and established in 2020, Suzhou Infinory Pharmaceuticals, LLC is a biopharmaceutical company primarily engaged in the development of oncolytic virus drug.
Where is Suzhou Infinory Pharmaceuticals headquartered?
Suzhou Infinory Pharmaceuticals is headquartered in Suzhou, China.
Which VCs invest in companies like Suzhou Infinory Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Suzhou Infinory Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Suzhou Infinory Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.